Condensed Consolidated Statements of Cash Flows $ in Thousands	9 Months Ended
	Sep. 30, 2024 USD ($)	Sep. 30, 2023 USD ($)	Dec. 31, 2022 USD ($)
Operating activities:
Net loss	$ (395,120)	$ (50,765)
Adjustments to reconcile net loss to net cash used in operating activities:
Depreciation and amortization	4,711	5,001
operating lease, right-of-use asset, periodic reduction, net	(285)	2,133
Stock-based compensation	23,933	31,448
Deferred income taxes	296,759	(17,964)
Operating Lease, Impairment Loss	3,276	0
Other	(627)	(1,968)
Changes in operating assets and liabilities:
Accounts receivable, net	(41,746)	(30,630)
Inventory	(48,993)	(27,745)
Prepaid expenses and other assets	(4,650)	(6,895)
Accounts payable and other liabilities	64,807	25,712
Deferred revenue	(2,107)	(4,919)
Net Cash Provided by (Used in) Operating Activities	(100,042)	(76,592)
Investing activities:
Purchases of property and equipment, net	(3,623)	(985)
Purchases of marketable securities	0	(25,782)
Maturities of marketable securities	24,000	134,204
Payments for (Proceeds from) Other Investing Activities	12,308	0
Net cash provided by investing activities	8,069	107,437
Financing activities:
Proceeds from issuance of common stock	2,150	3,876
Payment, Tax Withholding, Share-based Payment Arrangement	(2,847)	(7,146)
Payments for Repurchase of Common Stock	0	(30,000)
Net cash used in financing activities	(697)	(33,270)
Effect of Exchange Rate on Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents	157	(326)
Cash and cash equivalents	130,195	220,984
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents, Period Increase (Decrease), Including Exchange Rate Effect	$ (92,513)	$ (2,751)
Cash, Cash Equivalents, Restricted Cash and Restricted Cash Equivalents			$ 223,735